Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Learning from previous responses in phase I dose-escalation studies.

J Whitehead1, Y Zhou, N Stallard

  • 1Medical and Pharmaceutical Statistics Research Unit, The University of Reading, PO Box 240, Earley Gate, Reading, Berkshire, RG6 6FN. j.r.whitehead@reading.ac.uk

British Journal of Clinical Pharmacology
|July 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rurality, Deprivation and Ethnicity in New Zealand: Population Distributions and Intersecting Impacts on Mortality.

The Australian journal of rural health·2026
Same author

The multifaceted implications of mental fatigue on women's football players' performance in small-sided games.

Psychology of sport and exercise·2025
Same author

Expanding the all-hazards approach to include extreme cold weather: optimising emergency medical care.

BMJ military health·2025
Same author

Stressors faced by forcibly displaced Ukrainians in England within 6 months of arrival: A qualitative study.

Social science & medicine (1982)·2025
Same author

Oncocytic papillary cystadenoma.

British dental journal·2024
Same author

Experiences of UK and Irish family carers of people with profound and multiple intellectual disabilities during the COVID-19 pandemic.

BMC public health·2023

Statistical methods for dose escalation in early phase clinical trials are underutilized. This paper reviews formal approaches, like the Continual Reassessment Method, to improve trial design and execution.

Area of Science:

  • Clinical pharmacology
  • Biostatistics
  • Drug development

Background:

  • Phase I clinical studies typically rely on expert judgment for dose escalation.
  • Formal statistical methods for dose escalation are not widely implemented.

Purpose of the Study:

  • To describe statistical approaches for formalizing dose escalation procedures in Phase I studies.
  • To encourage further exploration and implementation of these methods.

Main Methods:

  • Review of proposed statistical methodologies for dose escalation.
  • Discussion of the Continual Reassessment Method (CRM) in oncology.

Main Results:

  • Several statistical approaches for dose escalation exist but have seen limited practical application.

Related Experiment Videos

  • The Continual Reassessment Method is noted for its use in oncology.

    • Conclusions:

    • Formal statistical methods can enhance the rigor of dose escalation in Phase I trials.
    • Collaboration between clinical pharmacologists and statisticians is crucial for overcoming limitations and improving implementation.